|
Profile
|
Delegates :
Hodaka Fujii |
|
Incorporated :
August 4 , 2023 |
Paid in Capital :
2 Million yen |
Employees :
1 人 |
Address :
3-7-14,Waseda,Hirosaki-City,Aomori AOMORI
〒036-8087
|
TEL/FAX :
090-6060-4696 / |
URL:
https://platinaplasmids.co.jp/en/ |
Attachment :
|
Mission/Background :
PlatinaPlasmids, Inc. is a bio-venture start-up originated from Prof. Hodaka Fujii lab at Hirosaki University founded in 2023. Some plasmids used in gene therapy, mRNA vaccine production, etc. can be difficult to propagate because of repetitive sequences and other factors. Our proprietary technology enables mass amplification of such problematic plasmids. Utilizing such basic biotechnologies, we can support the state-of-the-art medicine and contribute to proliferation of health and wealth of human beings.
|
Technology & Business
|
Our proprietary technology can avoid recombination or other disastrous changes in plasmids in E. coli. Since plasmids can be amplified in E. coli, large scale production of plasmids can be achieved economically.
Compared to in vitro DNA fragment / plasmid amplification, it is not necessary to insert an additional replication origin, and widely used plasmid vector can be directly used. Therefore, labor is less, cost is much lower, and yields are much larger.
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Amplification service of plasmids whose amplification is difficult by conventional methods
|
Launched
|
We amplify plasmids whose amplification is difficult by conventional methods
|
Acquisition of customers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
・Our service of amplification of plasmids for research use has been released from Funakoshi, Co. Ltd. (April, 2024) ・PlatinaPlasmids was selected as recipient of grant from Hirosaki city. (June, 2024)
|
Alliance strategy
|
・Please place orders for amplification of plasmids for research use through Funakoshi Co. Ltd (https://www.funakoshi.co.jp/contents/70889). ・If you have plan to use plasmids for non-research use such as production of drugs, please contact us directly.
|
|
|